Rhenium(V) and Technetium(V) Oxo Complexes of an N(2)N'S Peptidic Chelator: Evidence of Interconversion between the Syn and Anti Conformations.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Inorganic Chemistry

• Publication date

  1997-12-03

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/IC9706562PMID 11670202
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeted proteins for diagnostic imaging: does chemistry make a difference?

  1992cited by this paper

• Phase I Clinical Study with the GRPR-Antagonist [99mTc]Tc-DB8 for SPECT Imaging of Prostate Cancer: Does the Injected Peptide Mass Make a Difference?

  2025cites this paper
• Assessment of DNA/RNA Deregulation in Cancer Using 99mTc-Labeled Thiopurine

  2024cites this paper
• Bifunctional chelators for radiorhenium: past, present and future outlook.

  2022cites this paper
• Synthesis, characterization and biological studies of rhenium, technetium-99m and rhenium-188 pentapeptides.

  2019cites this paper
• The Radiopharmaceutical Chemistry of Technetium-99m

  2019cites this paper
• Development of PSMA inhibitors for molecular imaging and radio-guided surgery of prostate cancer

  2018cites this paper
• Radioactive Transition Metals for Imaging and Therapy.

  2018cites this paper
• BLOOD BRAIN BARRIER PERMEATION PEPTIDES CROSS-REFERENCE TO RELATED APPLICATIONS

  2017cites this paper
• New small 99mTc-labeled peptides for HER2 receptor imaging.

  2017cites this paper
• Synthesis and evaluation of novel Tc-99m labeled NGR-containing hexapeptides as tumor imaging agents.

  2015cites this paper
• Coordination Chemistry in Biology and Medicine

  2015cites this paper
• Evaluation of ανβ3-Mediated Tumor Expression with a 99mTc-Labeled Ornithine-Modified RGD Derivative During Glioblastoma Growth In Vivo

  2014cites this paper
• Novel Tc-99m labeled ELR-containing 6-mer peptides for tumor imaging in epidermoid carcinoma xenografts model: a pilot study

  2013influential citation
• angiogenesis imaging agent

  2013cites this paper
• Biological evaluation of an ornithine-modified (99m)Tc-labeled RGD peptide as an angiogenesis imaging agent.

  2013cites this paper
• Complexes of an Alpha Thymosin Derivative with 185/187Re and 99mTc: Structural Analysis and Initial Biological Evaluation

  2012cites this paper
• Structural modifications of ⁹⁹mTc-labelled bombesin-like peptides for optimizing pharmacokinetics in prostate tumor targeting.

  2012cites this paper
• Synthesis and evaluation of novel Tc-99m labeled probestin conjugates for imaging APN/CD13 expression in vivo.

  2012cites this paper
• Structure/reactivity relationships and mechanism from X-ray data and spectroscopic kinetic analysis

  2011cites this paper
• 99m Tc: Labeling Chemistry and Labeled Compounds

  2011cites this paper
• Single amino acid chelates (SAAC): a strategy for the design of technetium and rhenium radiopharmaceuticals.

  2009cites this paper
• Spacer site modifications for the improvement of the in vitro and in vivo binding properties of (99m)Tc-N(3)S-X-bombesin[2-14] derivatives.

  2009cites this paper
• Structural assessment and biological evaluation of two N3S bombesin derivatives.

  2009cites this paper
• Possible mechanisms of controlling the configuration, stability, and lipophilicity of [99mTcO]N3S and [ReO]N3S chelates

  2008cites this paper
• Assessment of macrocyclic triamine ligands as synthons for organometallic 99mTc radiopharmaceuticals.

  2008cites this paper
• Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides.

  2008cites this paper
• MO tripeptide diastereomers (M=99/99mTc, Re): models to identify the structure of 99mTc peptide targeted radiopharmaceuticals.

  2007cites this paper
• Isolation, characterization, and biological evaluation of syn and anti diastereomers of [(99m)Tc]technetium depreotide: a somatostatin receptor binding tumor imaging agent.

  2007cites this paper
• Somatostatin receptor-binding peptides suitable for tumor radiotherapy with Re-188 or Re-186. Chemistry and initial biological studies.

  2007cites this paper
• Solid‐phase Synthesis of a Peptide Derivative of Thymosin alpha1 and Initial Studies on its 99mTc‐Radiolabelling

  2007cites this paper
• First examples of neutral rhenium(V) complexes with a novel semi-rigid ligand containing a P,N,N,S donor atom set: Synthesis, characterisation and crystal structure

  2007cites this paper
• Tetra­phenyl­phospho­nium [N‐(2‐amino­phenyl)‐2‐(mercaptomethyl­carbonyl­amino)ethanamido(4−)‐κ4S,N,N′,N′′]oxorhenate(V)

  2007cites this paper
• Rhenium(V) oxocomplexes with novel pyrazolyl-based N4- and N3S-donor chelators.

  2006cites this paper
• Recent advances on technetium complexes: coordination chemistry and medical applications¶

  2006cites this paper
• Permeation Peptide Conjugates for In Vivo Molecular Imaging Applications

  2006cites this paper
• Preparation of cyclotron-produced 186Re and comparison with reactor-produced 186Re and generator-produced 188Re for the labeling of bombesin.

  2006cites this paper
• New directions in the coordination chemistry of 99mTc: a reflection on technetium core structures and a strategy for new chelate design.

  2005cites this paper
• Technetium-99m labeling of N-[N-(3-diphenylphosphino propionyl)glycyl]cysteine (PN2S-OH) and its methyl ester derivative (PN2S-OMe).

  2004cites this paper
• Structural study by NMR of an oxorhenium-RGD decapeptide complex for application in radiotherapy.

  2004cites this paper
• Binding of the oxo-rhenium(V) core to methionine and to N-terminal histidine dipeptides.

  2004cites this paper
• Bifunctional chelates with aliphatic amine donors for labeling of biomolecules with the {Tc(CO)3}+ and {Re(CO)3}+ cores: the crystal and molecular structure of [Re(CO)3{(H2NCH2CH2)2 N(CH2)4CO2Me}]Br ☆

  2004cites this paper
• The [(99m)Tc(N)(PNP)](2+) metal fragment: a technetium-nitrido synthon for use with biologically active molecules. The N-(2-methoxyphenyl)piperazyl-cysteine analogues as examples.

  2003cites this paper
• Synthesis of target-specific radiolabeled peptides for diagnostic imaging.

  2003cites this paper
• Radiochemical investigations of (99m)Tc-N(3)S-X-BBN[7-14]NH(2): an in vitro/in vivo structure-activity relationship study where X = 0-, 3-, 5-, 8-, and 11-carbon tethering moieties.

  2003cites this paper
• Synthesis and characterization of novel 99gTc(V) and Re(V) complexes with water-soluble tetraaza diamido dipyridino ligands: single-crystal X-ray structural investigations of mono- and dinuclear complexes.

  2003cites this paper
• Structure of a novel nitrido technetium complex with the peptide chelate ligand KYCAR

  2003cites this paper
• 5.3 – Rhenium

  2003cites this paper
• Synthesis and biological evaluation of EC20: a new folate-derived, (99m)Tc-based radiopharmaceutical.

  2002cites this paper
• State-of-the-art coordination chemistry of radioactive elements

  2002cites this paper
• The Molecular and Electronic Structure of [ReOX3(AsPh3)(OAsPh3)] Complexes (X = Cl, Br)

  2002cites this paper
• Tuftsin receptor-binding peptide labeled with technetium: chemistry and preliminary in vitro receptor-binding study.

  2001cites this paper
• Evolution of Tc-99m in diagnostic radiopharmaceuticals.

  2001cites this paper
• The solid phase synthesis and NMR spectroscopy of a 99Tc chelate–bombesin derived peptide conjugate

  2001cites this paper
• Technetium(V) oxo complexes of substituted propylene diamine dioxime (PnAO) ligands: water-dependent interconversion between syn and anti isomers.

  2001cites this paper
• Substitution Studies of Second- and Third-Row Transition Metal OXO Complexes

  2000cites this paper
• A solid-phase technique for preparation of no-carrier-added technetium-99m radiopharmaceuticals: application to the streptavidin/biotin system.

  2000cites this paper
• Chemistry of the rhenium-azopyridine family: an oxo parent and derivatives thereof including a novel oxo-imido dimer.

  2000cites this paper
• Syntheses and structures of technetium(V) and rhenium(V) oxo complexes of peptide having KYC-sequence

  2000cites this paper
• Novel Tat-peptide chelates for direct transduction of technetium-99m and rhenium into human cells for imaging and radiotherapy.

  2000cites this paper
• Technetium-99m RP527, a GRP analogue for visualisation of GRP receptor-expressing malignancies: a feasibility study

  2000cites this paper
• The syntheses and structures of '3+2' and '2+2+1' oxorhenium mixed-ligand complexes employing 8-hydroxy-5-nitroquinoline as the bidentate N,O donor ligand.

  2000cites this paper
• Targeting hypoxia in tumors using 2-nitroimidazoles with peptidic chelators for technetium-99m: effect of lipophilicity.

  2000cites this paper
• An N2S2 bifunctional chelator for technetium-99m and rhenium: complexation, conjugation, and epimerization to a single isomer.

  1999cites this paper
• Therapeutic radiopharmaceuticals.

  1999cites this paper
• Synthesis, structure and properties of [ReVL(O)Cl3], [ReVL(NR)Cl3], [ReIIIL(OPPh3)Cl3], and [ReIIIL(PPh3)Cl3] [L = 2-(arylazo)-1-methylimidazole, R = aryl]†

  1999cites this paper
• Synthesis and evaluation of two technetium-99m-labeled peptidic 2-nitroimidazoles for imaging hypoxia.

  1999cites this paper
• Structural characterisation and bioconjugation of an active ester containing oxorhenium(V) complex incorporating a thioether donor

  1998cites this paper